CervoMed Inc. (CRVO)

CervoMed Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	131	43	10	31	51	2
Market Cap Growth	1598.33%	319.78%	-66.82%	-38.92%	2253.73%	-67.82%
Enterprise Value	124	36	19	-6	33	-12
PE Ratio	-	-19.93	-1.78	-1.29	-3.15	-0.18
PS Ratio	20.56	6.06	-	-	-	-
PB Ratio	24.52	5.87	-0.31	0.89	2.05	0.11
P/FCF Ratio	-36.81	-5.81	-4.01	-2.14	-3.76	-0.22
P/OCF Ratio	-36.81	-5.81	-4.01	-2.14	-3.76	-0.22
EV/Sales Ratio	19.55	4.97	-	-	-	-
EV/EBITDA Ratio	-28.39	-16.35	-3.21	0.25	-2.06	1.04
EV/EBIT Ratio	-28.39	-16.35	-3.21	0.25	-2.05	1.03
EV/FCF Ratio	-35.18	-4.77	-7.24	0.43	-2.40	1.19
Debt / Equity Ratio	-	-	-0.37	-	0.01	0.01
Debt / EBITDA Ratio	-	-	-2.14	-	-0.01	-0.02
Debt / FCF Ratio	-	-	-4.83	-	-0.01	-0.03
Quick Ratio	2.39	3.35	0.31	12.75	7.60	8.24
Current Ratio	2.99	3.84	0.32	12.92	7.71	8.51
Asset Turnover	0.56	0.51	0	0	0	0
Interest Coverage	-	-	-9884.94	-	-	-
Return on Equity (ROE)	-53.00%	-18.30%	-48.30%	-54.50%	-61.90%	-75.20%
Return on Assets (ROA)	-42.40%	-15.50%	-24.90%	-51.40%	-55.30%	-62.70%
Return on Capital (ROIC)	-188.20%	-105.91%	16.65%	-70.68%	-63.99%	-56.68%
Earnings Yield	-3.70%	-5.02%	-56.26%	-77.51%	-31.71%	-545.71%
FCF Yield	-2.99%	-17.21%	-24.94%	-46.64%	-26.63%	-455.94%
Buyback Yield / Dilution	-1090.89%	-413.65%	60.08%	-80.83%	-702.68%	-106.84%
Total Shareholder Return	-1090.89%	-413.65%	60.08%	-80.83%	-702.68%	-106.84%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).